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ABSTRACT
The main post-polio syndrome (PPS) symptoms are new weakness, new atrophy, fatigue, pain 
and sleep disturbances. Polysomnography is the gold standard for sleep analysis. Objective: 
To analyze sleep patterns in PPS patients. Method: Sixty patients (mean age 46.8±11.3 years) 
at the Federal University of São Paulo (UNIFESP/EPM) complaining of  sleep disturbances 
were evaluated by means of polysomnography, performed at the Sleep Institute. Results: 
Sleep efficiency was lower due to high sleep latency and arousal index. The apnea and 
hypopnea index (AHI) and the periodic limb movements (PLM) index were higher. Sleep 
architecture was also impaired. There were no abnormalities of oxygen saturation, carbon 
dioxide levels, respiratory rate or heart rate. Conclusion: New post-polio sleep disturbances 
were isolated symptoms. It appears that these symptoms were not due to post-polio features, 
but rather, that they were due to dysfunction of the surviving motor neurons in the brainstem. 
Abnormal dopamine production, which is responsible for many sleep-related breathing 
disorders and abnormal movements, may also have been implicated in the present findings. 
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Análise das características do sono em pacientes com síndrome pós-poliomielite
RESUMO
Dentre as manifestações clínicas da síndrome pós poliomielite (SPP) destacam-se nova 
fraqueza, fadiga, dor, nova atrofia e transtornos do sono. A polissonografia de noite inteira 
permanece sendo padrão ouro para análise do sono e diagnóstico de transtornos do sono. 
Objetivo: Verificar os transtornos de sono nos pacientes com SPP. Método: 60 pacientes 
com SPP (media de idade 46,8±11,3 anos), da UNIFESP/EPM,que apresentavam queixas 
sobre sono realizaram uma noite de polissonografia no Instituto do Sono. Resultados: A 
eficiência do sono é diminuída em decorrência do aumento da latência do sono e do índice 
de despertar. O índice de apnéia e hipopnéia (IAH) e o índice de movimentos periódicos 
dos membros (iPLM) estão aumentados. A arquitetura do sono é prejudicada por essas 
alterações. Não há alterações da saturação da oxi-hemoglobina, do gás carbônico exalado, 
da freqüência respiratória e cardíaca. Conclusão: Novas alterações do sono são sintomas 
isolados desta população. Parece que esses sintomas não ocorrem devido a outras 
características da SPP, mas decorrem de disfunções nos neurônios do tronco encefálico e 
alterações da produção de dopamina que provocam os distúrbios respiratórios do sono 
e os movimentos periódicos dos membros.
Palavras-chave: sono, polissonografia, síndrome pós-poliomielite.
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The post-polio syndrome (PPS) de-
scribes  new neuromuscular symptoms ap-
pearing at least 15 years after achieving clin-
ical stability of patients who had previously 
presented poliomyelitis. The main clinical 
manifestations of PPS are new weakness, 
fatigue, pain, intolerance of cold tempera-
tures, new atrophy and sleep disturbances1,2.
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The most frequent sleep disturbances in PPS patients 
are obstructive sleep apnea (OSA) and period limb move-
ments (PLM). Overall, these are responsible for the poor 
sleep quality. The frequency of sleep-disordered breath-
ing (SDB) seems to be higher in patients with previous 
polio than in the general population3.
From the anatomical and pathological points of view, 
the bulb region in the brainstem could be affected by the 
poliovirus, thereby leading to impairment of the sleep 
regulator center. This may have a direct relationship to 
the sleep-related clinical manifestations of PPS4.
Our clinical experience led us to hypothesize that 
PPS patients with sleep complaints might present SDB 
or PLM, and that their physical symptoms might be ex-
acerbated due to this disorder. Therefore, sleep charac-
teristics were analyzed and correlated with symptoms of 
pain, fatigue, headache and sleep complaints, including 
daily hypersomnolence.
METHOD
The present report is a descriptive analytical study, 
carried out among patients presenting previous polio-
myelitis sequelae. PPS had been diagnosed over one year 
earlier. This study was approved by the Research Ethics 
Committee of the Federal University of Sao Paulo, under 
number 0152/05, in March 2005.
From January 2003 to December 2006, 199 patients 
with previous poliomyelitis underwent both a clinical 
evaluation at the Neuromuscular Sector of the Federal 
University of São Paulo (UNIFESP/EPM) and a polysom-
nographic evaluation at the Sleep Institute of UNIFESP/
EPM. From this group of 199 patients, 166 (80.4%) had 
had PPS diagnosed and were selected to enter the study. 
In a randomized manner, 60 patients were selected for 
a clinical evaluation. All of them signed the free and in-
formed consent statement. Fatigue (fatigue severity scale), 
pain (visual analog scale) and daily somnolence (Epworth 
sleepiness scale) were evaluated. Intolerance to cold, 
memory and concentration complaints and headache 
were also investigated. After this evaluation, these patients 
underwent a whole-night polysomnographic evaluation.
The polysomnographic evaluation was conducted at 
night, in a dark and silent room. The sleep data were re-
corded from 10 pm to 7 am. The following parameters 
were measured and recorded by a computer system (Al-
ice Respironics®, Marieta, GA, USA): [1] electroencepha-
logram (C3/A2, C4/A2, O1/A2, O2A1); [2] left and right 
electrooculogram; [3] submentonian electromyography; 
[4] anterior tibialis electromyography; [5] electrocardiog-
raphy; [6] abdominal and thoracic movement, with elec-
tric transducer; [7] oral and nasal flow and / or [8] nasal 
pressure cannula; [9] body position sensor; [10] partial 
pressure of carbon dioxide at end of expiration (PETCO2); 
and [11] percutaneous oxy-hemoglobin saturation (SpO2) 
(Ohmeda® Biox 3740 Louisville, CO, USA).
The sleep stage was established using the Re-
chtschaffen and Kales criteria5. Total register time (TRT), 
total sleep time (TST), sleep latency (SL), sleep efficien-
cy (SE), REM-sleep latency, arousal index, stage changes, 
percent of TST for stages 1, 2, 3 and 4 of non-REM sleep 
and REM sleep were assessed. Oxy-hemoglobin percuta-
neous saturation while awake, non-REM and REM sleep, 
Nadir, carbon dioxide partial pressure at the end of expi-
ration (PETCO2) while awake, non-REM and REM sleep, 
and peak CO2 were also assessed. The variables of SDB 
(number of obstructive apnea, central apnea, mixed ap-
nea, hypopnea, and apnea and hypopnea index (AHI) 
were measured. Sleep apnea syndrome was defined as: 
mild, with AHI ranging from 5 to 15 events per hour; 
moderate, when ranging from 16 to 30 events per hour; 
or severe, with more than 31 events per hour. Periodic 
limb movements (PLM) were defined as mild when AHI 
ranged from 5 to 24 events per hour; moderate when it 
ranged from 25 to 49 events per hour; or severe, with 
more than 50 events per hour.
Obstructive sleep apnea (OSA) was defined as an up-
per airway blockage during sleep without bulb impair-
ment. Obstructive sleep apnea syndrome (OSAS) was 
classified as: mild, when AHI ranged from 5 to 14 events 
per hour; moderate, when AHI ranged from 15 to 29 
events per hour; or severe, when AHI was greater than 
30 events per hour. For AHI greater than 14 events per 
hour, BiPAP was indicated.
The severity of periodic limb movements index 
(PLMi) was classified by means of the polysomnograph-
ic examination as: mild, PLM from 5 to 24 events per 
hour; moderate, PLM from 25 to 49 events per hour and 
severe, PLM higher than 50 events per hour.  
A group totaling 60 patients was studied: 39 were fe-
male, i.e. 65%; mean age 46.8 years (ranging from 32 to 
59 years); median age 47 years for men and 48 years for 
women (Table 1). All patients fulfilled the post-polio cri-
teria from the 2001 conference.
Statistical analysis
Descriptive analysis was used for comparisons of per-
centages, for odds calculation, as well as for mean and 
median values, with the respective standard deviation. 
The chi-square test (c2) was used for categorical data.
The continuous variables were tested for parametric 
distribution using the Kolmogorov-Smirnov test.
Results were considered to be statistically significant 
for an alpha error of 5% (p<0.05). The calculations were 
done and graphs were made using the STATISTICA soft-
ware, version 5.1 (Statsoft, Inc, Tulsa, OK, USA) and Mi-
crosoft Excel (Version 2003 SP2, Portland, OR, USA).
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RESULTS
This group of patients presented lower sleep efficien-
cy, higher arousal index, higher REM latency and a larg-
er number of stage changes. PLM index >5 per hour and 
AHI >5 per hour were present in most patients. The mean 
level of oxy-hemoglobin saturation (SpO2) was between 
90% and 95%, while the SpO2 low values were between 
58% and 96%. The mean carbon dioxide partial pressure 
(PETCO2) was 35 mmHg, with a peak at 40 mmHg. Re-
spiratory rates were lower than 16 breaths per minute, 
while the heart rate was between 74 and 85 beats per 
minute (Table 2).
The symptoms of intolerance to cold, fatigue and sleep 
abnormalities were the most frequent findings in 73.3%, 
80% and 78.3% of patients, respectively. Pain and head-
ache were present in more than 50% of the patients, while 
other symptoms were less frequently observed (Table 3).
DISCUSSION
The present study was performed prospectively. The 
data and results were analyzed by the same person. Ten 
patients (16.6%) used non-invasive nocturnal ventilation 
during testing, due to obstructive sleep apnea (OSA). 
Bach6 reported that 15% of PPS patients needed noctur-
nal non-invasive ventilation (NNIV) because of higher 
AHI, oxy-hemoglobin desaturation and CO2 retention. 
The PPS sleep characteristics are similar to other neu-
romuscular disorders affecting the sleep profile, but PPS 
has some particular features. 
Table 1. Social and demographic characteristics of post-polio 
syndrome patients. 
N % 
Age, years 46.8±11.3
Sex
  Male
  Female
  Total
21
39
60
35
65
100
Race
  Caucasian
  Black
  Asian
51 
3 
6  
85
5
10
Total 60 100
Table 2. Sleep quality of post-polio syndrome patients.
Polysomnographic parameters Mean±SD Maximum Minimum
Total sleep time, min 324.9±73.3 461 163
Sleep efficiency, % 69.2±14.9 98.6 34.8
Sleep latency, min 40.1±35.1 163 0
REM sleep latency, min 121.7±71.9 353.5 2.5
Arousal index, n/h 9.9±11.5 53.6 0.9
Stage changes, n/h 72.7±25.2 170 38
PLM, n 45.7±105.3 697 0
PLM, n/h 5.3±11.1 44.7 0
SpO2 REM, % 94.2±2.5 98 84
SpO2 NREM, % 94.1±2.3 97 85
SpO2 baseline, % 94.2±2.1 98 87
Nadir SpO2 , % 86.5±8.6 96 58
PETCO2 awake, mmHg 33.8±4.3 45 25
PETCO2 REM, mmHg 34.4±5.3 44 18
PETCO2 NREM, mmHg 34.4±4.3 44 23
Pico CO2, mmHg 41.8±4.4 53 35
AHI, n/h 6.2±14.5 80.4 0
Number of obstructive apnea, n/h 19.2±54.9 261 0
Number of central apnea, n/h 1.1±3.9 23 0
Number of mix apnea, n/h 1.4±6.5 41 0
Hypopnea, n/h 13.4±26.3 181 0
Breathing rate awake, rpm 14.5±3.7 24.9 12
Breathing rate REM, rpm 14.3±4.5 23 12.5
Breathing rate NREM, rpm 15.9±10 81.5 12.7
Heart rate awake, bpm 84.4±30.3 89.6 53.2
Heart rate REM, bpm 75.4±19.6 86.4 50.1
Heart rate NREM, bpm 74.7±22 88.5 46.9
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In the present report, sleep efficiency (SE) was de-
creased (lower than 85%) in 44 of the 60 patients, ranging 
from 67.4% (patients using non-invasive ventilation) to 
69.5% (patients not using non-invasive ventilation). This 
reduced SE is likely to reflect the arousals during sleep 
(average of 10 events per hour), as well as sleep-related 
disordered breathing and PLM, which are both frequent 
in PPS populations. Abnormal movements during sleep 
have been described in patients with PPS. From polysom-
nographic examination, it was observed that these move-
ments were diversified, and were present in 63% of the 
PPS patients7.
According to Steljes et al.8, the sleep efficiency of PPS 
patients with sleep complaints was 52.2%, the arousal in-
dex was 30.5 events per hour, AHI was 56.4 events per 
hour and the mean SpO2 during the night was 90%. Ac-
cording to other authors, the PPS patients sleep efficien-
cy was 89.3%, with a high PLM index reported in 24.8% 
of the patients9.
Respiratory impairment (AHI) was observed in the 
present study, ranging from 0 to 80.4 (mean of 6.2±14.5) 
events per hour. On the other hand, oxy-hemoglobin sat-
uration and exhaled CO2 did not show changes in this 
population. 
For the present PPS population, the abnormalities in 
the polysomnographic examination and in the sleep ar-
chitecture indicated decreased sleep quality. This was evi-
dent from the greater time spent in superficial sleep stag-
es (73.6% of TST), to the detriment of slow-wave sleep 
(7.8% of TST) and REM sleep (18.7% of TST). These find-
ings were similar to those of Hsu et al.8, who reported that 
71.1% of TST was spent in superficial sleep stages, 14.7% 
of TST in slow-wave sleep and 14.1% of TST in REM sleep. 
The difficulties observed among PPS patients regard-
ing deepening of sleep and entering REM sleep are be-
lieved to be due to impaired reticular formation due to the 
poliovirus. This difficulty seems to be more pronounced 
in patients with bulb injury10.
It has been reported that 13% of PPS patients pre-
sented difficulties in remaining asleep, 8% had difficul-
ty in falling asleep and 25% had PLM, which can also im-
pair sleep deepening and, at the same time, can facili-
tate arousal11.
The results from the present study showed the preva-
lence of PPS symptoms to be as follows: cold intolerance 
appeared as a complaint among 83.3% of the patients, fa-
tigue in 80%, sleep abnormalities in 78.3%, chronic head-
ache in 70% and pain in 56.6%.
Cold intolerance is reported to be very prevalent in 
the Brazilian population as a complaint (in 46%12) and in 
69.8% of the worldwide PPS population13. This prevalent 
symptom can decrease the sensation of muscle strength 
in  these individuals14.
Fatigue is a frequent and debilitating symptom of PPS, 
and its prevalence ranges from 48%15 to 87%16,17 For the 
Brazilian PPS population, the prevalence of fatigue rang-
es from 66%18 to 77.5%12. About 41% of PPS patients re-
port that fatigue significantly influences the execution of 
tasks, while 25% of the patients report that fatigue influ-
ences their personal care activities. It has been reported 
that fatigue was provoked or exacerbated by intense phys-
ical activity and by emotional stress in 92% and 61% of the 
participants, respectively.13 The exacerbation of fatigue 
carries complications, mainly  affecting strength, thereby 
leading to pain and inducing sleep abnormalities19.
Poor quality of sleep was reported by about 70% of the 
Brazilian PPS patients in a previous study12. The main rea-
son for this finding seems to be sleep-related disturbanc-
es8. In a report  on over 600 PPS patients, 63% reported 
that their muscles jumped during their sleep, leading to 
fragmented sleep in 52% of these patients7.
Morning headache is, in most cases, caused by bad 
encephalic oxygenation and CO2 retention during sleep. 
Up to 45% of Brazilian PPS patients reported this symp-
tom and correlated it with disordered breathing dur-
ing sleep12. However in the present study, no CO2 reten-
tion or O2 desaturation was observed, but  70% of the pa-
tients reported this symptom because of apnea and PLM. 
Pain was a symptom reported by 43% to 80%17 of PPS pa-
tients. Studies in Brazil have shown different prevalences 
Table 3. Symptoms of post-polio syndrome patients.
Symptoms Patients, n (%) Maximum Minimum
Fatigue (FSS >28) 48 (80) 63 9
Pain (VAS >5) 34 (56) 10 1
Morning headache (yes) 42 (70) – –
Cold intolerance (yes) 50 (83) – –
Memory impairment (yes) 27 (45) – –
Daily hyper somnolence (Epworth >12) 29 (48) 2 22
Sleep impairment (Mini-sleep >30) 47 (78) 60 12
Daily hypersomnolence (Stanford >4) 10 (16) 7 1
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for muscle and joint pain (76% and 79%, respectively)12. 
Other reports have shown joint pain rates of 55% to 79%, 
thereby leading to difficulty in falling asleep and main-
taining sleep, and decreasing sleep efficiency20. Thirty-
four of the patients evaluated here (56%) reported mus-
cle and/or joint pain, and these results were similar to 
those obtained in studies conducted both in Brazil and 
elsewhere. Ninety percent of these patients were able to 
walk independently or with the use of canes, walkers or 
orthoses, and most of them were still working. However, 
all of them made use of energy conservation  techniques. 
Trojan and Cashman21 reported that 50% of PPS patient 
presented chronic muscle and joint pain that might be re-
lated to fibromyalgia. 
Van Kralingena11 reported  that 35% of PPS patients 
with body mass index (BMI) over 45 kg/m2 present-
ed OSAS. In epidemiological studies, the prevalence of 
OSAS in healthy adults of the same age as the popula-
tion of the present study was 15%22. Duran et al.23 esti-
mated that the prevalence of OSAS was 15% among males 
aged 30 to 70 years. Among women, this prevalence was 
7%, and among the elderly, the prevalence increased to 
37.5%24. The high prevalence of OSAS among postmeno-
pausal women might be due to the absence of estrogens 
and progesterone, i.e. the hormones that  increase upper 
airway permeability and respiratory function25. Therefore, 
PPS patients present higher AHI than do general popula-
tions of adults, and lower AHI than do the elderly. 
Kalpakjan26 studied postmenopausal women with PPS 
and found exacerbation of daily hypersomnolence, along 
with psychological abnormalities, compared with post-
menopausal women without polio sequelae. In the pres-
ent study, 25 patients (41.5%) were women aged between 
47 and 59 years, which has to be taken into consider-
ation, since some PPS symptoms may be exacerbated by 
the menopause. 
Obstructive sleep apnea syndrome (OSAS) is caused 
by obstruction of the upper airway, due to increase vol-
umes of tissue around the airways, tonsils and adenoids, 
or increased uvula size27. Patients with PPS and OSAS 
may present respiratory problems, sleep arousals and 
decreased oxygen saturation due to brainstem lesions 
caused by the poliovirus. Dean et al.28 reported that PPS 
patients’ polysomnographic examinations showed un-
altered sleep architecture, but presented increased AHI 
(bulbar and non-bulbar polio), due to reduction of brain-
stem control during non-REM sleep. Iber et al.29 reported 
that 90% of PPS patients presented OSA, while 10% pre-
sented CSA and MSA. 
According to Hsu et al.9, 54.2% of PPS patients had 
OSAS, 20% had chronic alveolar hypoventilation (CAH) 
and 25.8% had both diagnoses. The symptoms of dyspnea, 
daily hypersomnolence, insomnia and new weakness were 
more frequent in patients with CAH than in patients with 
OSAS. Sleep-disordered breathing (SDB) seems to be a 
late sequela of poliomyelitis, and therefore clinical evalua-
tions on PPS patients should include information on sleep.
Bach3,6 reported  that one third of PPS patients made 
use of continuous positive airway pressure (CPAP) non-
invasive ventilation, and 14.5% of polio sequela patients 
used bi-level positive airway pressure (BiPAP) because of 
chronic alveolar hypoventilation (CAH). Forced vital ca-
pacity (FVC) can decrease by 1.9% a year in PPS patients 
because of fatigue and muscle weakness, which may ulti-
mately result in impaired concentration and memory, as 
well as decreased sexual desire. Respiratory muscle dys-
function, scoliosis and obesity can highlight these com-
plications. Ten PPS patients in the present study made use 
of BiPAP for OSAS, oxy-hemoglobin desaturation, hyper-
capnia and hypoventilation.
Decreased oxy-hemoglobin saturation during the 
night, when associated with hypercapnia, can predict 
morning headache. PPS patients may present decreased 
third and fourth-stage sleep, increased micro-arousals 
and PLM21,30, restless leg syndrome and insomnia30, and 
may frequently feel chronic pain. 
Thirteen patients (21.6%) in the present study had a 
PLM index >5 events per hour and six of them (15%) had 
a PLM index > 15 events per hour, as well as daily hyper-
somnolence (mean Epworth=12). An increased PLM in-
dex often has consequences, such as difficulties in deep-
ening sleep, increased arousals, inefficient sleep, leg tired-
ness and peripheral fatigue. An epidemiological study by 
Pennestri et al.31 showed an average PLM index in healthy 
adults (40 to 59 years old) ranging from 10 to 12 events 
per hour. Pallesen et al.32 reported that patients with 
PLM<5 event per hour only felt mild daily somnolence.
Bruno et al.7 described leg movements in PPS pa-
tients as myoclonus, ballistic movements and PLM, while 
Hornyak et al.33 reported that the presence of these move-
ments could decrease sleep efficiency, and increase both 
the number of arousals and the proportion of stage-one 
sleep. Neubauer24 concluded that the older the patient 
was, the higher the PLM index would be. 
Siegel et al.10 reported that REM sleep latency might 
be increased through long-term necessity to recruit mo-
tor neurons of the pontine tegument after polio dam-
age. Bourke and Gibson34 reported that TST and sleep 
efficiency were both decreased, probably as a reflection 
of muscle weakness, arousals and increased duration of 
stage one, especially among PPS patients with sleep-dis-
ordered breathing. 
The treatments for sleep disturbances have already 
been described in the literature. Treating sleep disturbanc-
es may lead to an improvement in the quality of life, there-
by decreasing the intensity of many limiting symptoms.
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In conclusion, the sleep quality of PPS patients was 
decreased due to impairment of sleep efficiency, arousals, 
changes in the different sleep stages, increased PLM in-
dex, OSAS, and increased percentages of stages 1 and 2. 
The main PPS symptoms were intolerance to cold (83.3%), 
fatigue (80%), sleep impairment (78.3%), headache (70%) 
and pain (56.6%). 
Polysomnographic evaluation is useful and essential 
for PPS patients with SDB and other impairments of sleep 
quality. 
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